Viral blips during long-term treatment with standard or double dose lamivudine in HBe antigen negative chronic hepatitis B
Articolo
Data di Pubblicazione:
2007
Abstract:
To evaluate safety and effect on hepatitis B virus (HBV) suppression of a long-term treatment with lamivudine (LAM) at standard (100 mg/d) or double (200 mg/d) dose in chronic hepatitis B.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Adult; Aged; Alanine Transaminase; DNA; Viral; Female; Hepatitis B e Antigens; Hepatitis B; Chronic; Humans; Lamivudine; Male; Middle Aged; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors
Elenco autori:
Stornaiuolo, Gianfranca; Stanzione, Maria; Brancaccio, Giuseppina; Cuomo, Gianluca; Precone, Vincenza; Di Biase, Sebastiano; Felaco, Francesca-M; Piccinino, Felice; Gaeta, Giovanni-B
Link alla scheda completa:
Pubblicato in: